Chapter 157: The Auction (Part II)
Yang Long, deputy secretary general of the municipal party committee, heard Zhuo Chuan say something reasonable, so he nodded, he didn't need to argue with the other party on this trivial matter, besides, the higher the sale, whether it was good for Zhuo Chuan or for him.
In the first round, several well-known international companies did not make offers.
Five minutes passed quickly, and everyone on the rostrum looked at the big screen and the highest bidder was no longer "Dongshan Medical", but a company called "Southeast Deep Sea Medical".
"Southeast deep-sea medical software, 43 million, 75% share, service official launch time, 6 months"
With the absolute advantage of quotation and sharing ratio, he won the first place in this round.
Seeing this, Deputy Secretary-General Yang smiled, he turned his head to Zhuo Chuan and said, "It seems that Mr. Zhuo's words are going to be fulfilled, this is only the first round of warm-up, it is close to half a billion, after ten rounds, the bidding price of one billion is not impossible, this is only the three eastern provinces that are not densely populated, if it is Qilu Province, Zhedong Province, I am afraid it will be several times,"
Yang Long thought that Zhuo Chuan's estimate was very accurate, of course he couldn't imagine that Zhuo Chuan relied on his extraordinary eyesight, and after a distance of seven or eight meters, he saw the small words written on the paper by those big manufacturers in the front row.
The host saw the end of the first round, so he picked up the microphone and said, "The first place in this round of bidding - Southeast Deep-sea Medical Software, congratulations to them, their offer will automatically enter the next round, as the reserve price, other people's bids shall not be lower than the price, and the lower one will not be shown with statistics."
This rule is normal, if there is a price lower than this price in the second round of bidding, and then count, isn't it a waste of everyone's attention and time, and the time of those who can come here to participate in the auction is very precious.
The second round of offers began soon.
Zhuo Chuan watched the people below fight on the stage for a long time, and before the auction, naturally there were many connections to him, but he let the Ministry of Commerce push it off. As for some companies that want to go through high-level relationships and get licenses privately, they are also greeted by people at the top level, saying that this auction should be done in strict accordance with the laws of the market, and put an end to the occurrence of greetings and relationships.
Acting according to the normal laws of the market is the best treatment for Zhuo Chuan now, because with his monopoly position in technology, no one will be able to break through in the next few decades, and he still has a whole world of new technologies waiting to be carried.
"Johnson & Johnson (Huaxia) Medical Branch, the quotation is 245 million, the share ratio is 55%, and the service is officially opened, 2 months"
The top spot in the second round came out quickly, and the top spot on the big screen shocked the other auction participants.
"More than 240 million, just a Northeast regional license, there are at least ten similar regions, it seems that Mr. Zhuo, your company is going to make money today," Deputy Secretary-General Yang said with envy. The money from the other party is very clean, which is most in line with the current trend of the times and the policy of support from the upper level of the state.
Relying on high technology to create new value, directly serving the fundamental needs of people, health needs, this is the best way to make money, making money itself, is to make a great contribution to the society, is the process of leaving a name in history.
Mr. Zhuo smiled, this was in his expectation, when he selected this technology to take it out, he expected it to appear today.
This technology seems incredible to many people. But in the new world, it is a very common technology, it was invented in 2045, before that, experienced a sudden explosion of science and technology, the cause of the outbreak, Zhuo Chuan did not find, only know that the discovery of these technological achievements, appeared quite abruptly, there is no pre-technology tree.
And if human beings in the modern world study step by step, it is difficult to get the same results in just a few decades.
It's no wonder that the companies below are so crazy, it's like penicillin, a drug that suddenly appeared in the 15th century, as long as you take a few bottles, it is very possible to change a fiefdom, because of high fever and bacterial infection, there are not too many royal descendants who died young.
The companies below were also in an uproar, and many people looked at the representatives of Johnson & Johnson, and the other party came up with such a high price in the second round, which obviously squeezed out many companies with insufficient cash flow at once. More than 200 million yuan in cash has to be taken out at once, which is difficult for many companies to do, and often requires financing.
After signing the contract, a large amount of cash flow will be transferred, which is stipulated before the auction, and if you can't get cash, you will be in breach of contract, and you will not only lose your reputation, but also be fined, and you will completely lose the possibility of cooperating with Tianhua Company in the future, and the loss will be very heavy.
Representatives of Johnson & Johnson are also slightly proud, and usually each company tries to claim how good they are on their own websites, at various expos, and when they promote various products. But that's all false, and only in this kind of direct bidding can we see the true strength of each company.
Their company is involved in a wide range of medical industries, is one of the pharmaceutical giants, and its profitability is not comparable to that of ordinary medical companies, ranking fourth among global pharmaceutical companies.
As for the world's top three pharmaceutical giants, Pfizer, GlaxoSmithKline, and AstraZeneca are the three, Pfizer is more famous in China, but this time they and the other two did not come to participate in the auction.
As for why they didn't come, they actually reached an upfront agreement with Johnson & Johnson, and Johnson & Johnson Medical will compete with other companies in the Asian market, while Europe and the United States, the two largest and most elite global markets, will give way to these three companies to compete.
In fact, all the companies around the world that are on the side of medical care, all of them have launched mergers and acquisitions after Zhuochuan announced the opening of intelligent ECG prediction physiological crisis cloud services.
They are in talks with a professional manufacturer of ECG monitoring equipment, and are ready to bring it under their umbrella for retrofit. So much so that for a time, among the listed companies on the NASDAQ, all the companies linked to the manufacture of ECG equipment have risen to varying degrees.
Companies like Johnson & Johnson, which have long been involved in the R&D and manufacturing of cardiovascular device products, have taken the lead and can quickly transform this technology into market products. It is said that they have begun to renovate the product on a large scale and reserved the network interface, which shows that the bid for this license is inevitable.
The three medical device giants in the first row were also a little unable to sit still at this time. They occupy the vast majority of the market share in the high-end medical equipment market in Huaxia, and they usually look down on small medical devices such as ECG monitoring.
But this time it is different, they will not be able to let go of this area, and if they do, it will lead to a total strategic mistake.
When it comes to financial strength, GE Healthcare is backed by a giant called General Electric, which has the strongest financial strength.
Although Philips and Siemens are also very famous, they are difficult to compare with GE Healthcare in terms of financial margin compared to the former. But at this time, no one will back down, and it is conceivable that whoever occupies the medical market of Huaxia, the world's second largest economy, will have extremely strong profitability and push the company to a new level.
Representatives of these three companies glanced at each other, and as rivals who had competed in China for many years, there was both competition and cooperation and compromise between them. Before coming here to bid, they exchanged opinions with each other, and each set up its own core bidding market to reduce conflicts.
But Johnson & Johnson's strong intervention made them very passive, of course, they had already expected this situation, the fat was too big, and many people had to grab it to eat, and there was no way to compromise and negotiate one after another, so the meat was not enough.
However, it is only a market in the three eastern provinces, and the other party will soar the price so high, which poses a lot of pressure on the bidding in their next few regions.